Sweet Orange Alcohol (Citrus sinensis / Citrus aurantium var. dulcis): A Comprehensive Reference
1. Identity and Nomenclature
1.1 Botanical and Chemical Names
Sweet orange is scientifically known as Citrus sinensis, belonging to the family Rutaceae, and is an important fruit globally. The INCI (International Nomenclature of Cosmetic Ingredients) naming system, which is used internationally on cosmetic labels, designates the plant as Citrus aurantium dulcis. This means the sweet orange ingredient is described in the INCI Dictionary as Citrus Aurantium Dulcis (Orange), whereas most published literature and the FDA Voluntary Cosmetic Registration Program refer to it as Citrus sinensis (Sweet Orange).
The term Sweet Orange Alcohol most precisely refers to an ethanolic (ethyl alcohol-based) extract of the peel, fruit, or both parts of Citrus sinensis. In this context, "alcohol" designates the solvent system and extraction vehicle — specifically ethanol — used to concentrate the bioactive constituents of the plant. The resulting liquid preparation is therefore a botanical alcohol extract, or tincture, of sweet orange. This is distinct from:
- Cold-pressed Citrus aurantium dulcis peel oil (CAS 8008-57-9), an expressed volatile oil;
- Sweet orange fruit water, an aqueous steam distillate;
- Sweet orange fruit extract (CAS 84012-28-2), which may be prepared with water, glycerin, or mixed solvents.
In INCI nomenclature, Citrus aurantium dulcis fruit extract is described as an extract of the fruit of the sweet orange, Citrus aurantium L. var. dulcis L., Rutaceae, with CAS numbers 8028-48-6 / 84012-28-2. When ethanol specifically serves as the extracting solvent, producers and formulators sometimes designate the product as "Sweet Orange Alcohol" to indicate the alcoholic preparation route.
1.2 Natural Source and Botanical Description
Sweet oranges belong to the Rutaceae family and are native to Southeast Asia. The sweet orange is a plant belonging to the Rutaceae family, with common characteristics including a tree height of 3–10 meters and short thorns almost all over the plant, and leaf stalks measuring approximately 0.5–3.5 cm. A citrus fruit is botanically classified as a type of berry called a hesperidium that has a thick, leathery rind with numerous oil glands, and a large flesh portion composed of several wedge-shaped sections.
The citrus fruit-derived ingredients are complex botanicals composed of numerous constituents; there is great variation among Citrus species and cultivars because of frequent bud mutations, interspecific and intergeneric hybridization, and apomixis. Valencia, Shamouti, and Sathgudi are among the recognized sweet orange types.
1.3 Common Forms and Preparations
The sweet orange (Citrus sinensis) fruit peel is one of the often overlooked parts of the sweet orange plant; however, recent research indicates that sweet orange peel possesses various bioactive properties and intriguing health benefits.
Sweet orange alcohol is prepared by macerating or percolating fresh or dried peel (and sometimes whole fruit) in ethanol or hydroethanolic solutions. Ethanol, with its higher polarity, may dissolve more plant constituents than non-polar solvents such as hexane, indicating that ethanol is a better solvent for the extraction of Citrus sinensis. The phytochemical analysis of the peel extracts indicated the presence of a variety of bioactive compounds such as alkaloids, flavonoids, phenols, saponins, tannins, phytosterols, diterpenes, and glycosides. Ethanolic extracts contain a higher number of secondary metabolites, with diterpenes being detected only in the ethanolic extracts.
Common forms encountered in commerce and research include:
- Ethanolic tinctures (hydroalcoholic macerations of dried peel, typically 1:5 or 1:10 in 40–70% ethanol)
- Standardized dry extracts produced by evaporating the ethanol solvent after extraction, yielding a concentrated powder
- Liquid extracts (1:1 in ethanol/water) used in herbal dispensing
- Cosmetic alcohol preparations incorporating sweet orange as a functional botanical
Some common solvents used in the extraction of phenolics are methanol, ethanol, propanol, acetone, and ethyl acetate. For food-grade and supplement preparations, ethanol is overwhelmingly the solvent of choice.
2. Traditional and Historical Use
2.1 Traditional Chinese Medicine
Citrus sinensis is a popular and commonly used ingredient in Traditional Chinese Medicine, with preparations derived from peels, young fruit, mature fruit, flowers, and other tissues. Peels from members of the sweet orange family have been used in Traditional Chinese Medicine at least since the writing of the Divine Husbandman's Classic of the Materia Medica, written in the second century BC.
In Traditional Chinese Medicine (TCM), the peel is used to invigorate the flow of life force, also known as qi, and is a common addition to formulas for those experiencing dampness in the body, which manifests as excess mucus or phlegm. In TCM, citrus peel is used to stimulate "Spleen Chi," which is a metabolic element of digestion; herbs for Spleen Chi aid the absorption and assimilation of nutrients from food by improving circulation and digestive fluids within the GI tract.
In Chinese traditional medicine, the orange has a long history as a cooling agent for coughs. In TCM clinical practice, Fructus aurantii (the dried mature fruit of related Citrus aurantium) is widely used as an expectorant and digestant herb with a variety of pharmacological functions.
2.2 Ayurvedic and South Asian Traditions
Citrus sinensis, commonly known as sweet orange, has a rich history of medicinal use dating back to ancient civilizations. Originating in Southeast Asia, its fruit, peel, and flowers were prized in traditional Chinese and Ayurvedic medicine, and the aromatic orange peel was widely used to alleviate digestive disorders, reduce bloating, and stimulate appetite. While not indigenous to ancient India, citrus fruits were incorporated into Ayurvedic practice over centuries of trade.
2.3 European Traditions
In Europe, orange peels and blossoms became popular remedies during the Renaissance for treating nervous tension, palpitations, and mild insomnia due to their calming properties. Historically, Citrus sinensis was valued for its high vitamin C content, making it an essential remedy against scurvy among sailors and explorers during long sea voyages. For centuries, across Europe, Asia, and Africa, parts of the orange have also been added to perfumes and toiletries for their mood-boosting and bright, lemony aroma. There are many traditional culinary uses for orange peel, such as Greek loukoumades, Italian panettone, and British marmalade.
2.4 Traditional Preparations and Purposes
It has been used traditionally to treat various ailments including constipation, cramps, colic, diarrhea, bronchitis, tuberculosis, cough, cold, obesity, menstrual disorder, angina, hypertension, anxiety, depression, stress, asthma, vomiting, fever, hiccoughs, and indigestion.
Traditional Chinese Medicine uses dried orange peel, or chen pi, for digestion and lung health, while Ayurveda and Italian herbal practices incorporate peels into teas, oils, and bitters.
The essential oil, extracted from the peel, was applied topically or inhaled to uplift mood and promote relaxation. Alcoholic extractions — tinctures prepared by soaking the dried peel in wine or spirit — were among the most traditional methods of concentrating the peel's volatile and non-volatile constituents for medicinal use, particularly in European herbal traditions.
3. Key Constituents and Active Compounds
3.1 Phytochemical Profile of the Ethanolic Extract
Sweet orange peel contains a variety of chemical compounds, including essential oils, flavonoids, carotenoids, steroids, terpenoids, alkane groups, and ethyl esters. Results from peer-reviewed analyses show that Citrus sinensis peel extracts contain alkaloids, flavonoids, phenols, phytosterols, diterpenes, tannins, and glycosides.
GC/MS analysis identified about 48 compounds in each extract, with the predominant bioactive compounds being limonene (16.5%), ascorbic acid (17.7%), stearic acid (26.3%), linalool (4.7%), linoleic acid (16.18%), palmitic acid (15.23%), and pentadecyclic acid (1.1%).
The GC/MS analysis of the samples revealed the presence of terpenes/terpenoids, esters, fatty acids, ketones, unsaturated polyhydroxy alcohols, and oxygenated compounds. Some bioactive compounds of importance identified in the extracts include d-limonene, linalool acetate, linalool, 1-octanol, beta-cubebene, n-hexadecanoic acid, pentadecanoic acid, 9,12-octadecanoic acid, octadecanoic acid, 1-(+)-ascorbic acid 2,6-hexadecanoate, cubenol, menthol, terpineol, citronellol, copaene, muurolene, elemol, 3-hexen-2-one, and oxazole.
3.2 Flavonoids
Hesperidin accounts for approximately 90% of the flavanone glycosides in orange juice and is mainly concentrated in the solid parts and membranes that separate the pulp segments of citrus fruits. Hesperidin is one of the bioflavonoids greatly found in Citrus species and is one of the major active constituents of sweet orange (Citrus sinensis) peel.
Chemical profiling of non-polar peel extract using GC-MS revealed volatile terpenic compounds (limonene, valencene, nootkatone, etc.), long-chain alkanes (tricosane, nonacosane, and triacontane), triterpenes (squalene, 2,3-oxidosqualene, and α-amyrin), phytosterols (γ-, β-sitosterols, fucosterol, cycloartenol, and 24-methylene cycloartanol), fatty acids (linoleic and palmitic acids), and polymethoxylated flavones (nobiletin, 3-methoxynobiletin, tangeretin, and tetramethyl-O-scutellarin).
Complementary HPLC-DAD analysis indicated that the flavanone glycosides (hesperidin and narirutin) and the flavonol quercetin were the basic components of the polar fraction.
A group of flavonoids — polymethoxyflavones (PMFs) — found abundantly and almost exclusively from citrus peels, have been given great attention because of their wide range of properties. Many in vitro experiments have elucidated anticancer actions by PMFs, including antiproliferation, enzyme inhibition, and cancer cell growth inhibition.
3.3 Terpenes and Volatile Compounds
D-limonene is the dominant terpene in sweet orange peel essential oil and the primary volatile compound captured in alcoholic extractions. Limonene and other terpene-rich citrus flavor ingredients, such as oil, essential oil, whole fruit extract, and peel extract, are generally recognized as safe (GRAS) by the FDA.
3.4 Mechanisms of Action of Key Compounds
Hesperidin, a flavonoid present in Citrus, has been shown to exhibit vasodilator, antihypertensive, antithrombotic, anti-inflammatory, antilipemic, and antioxidant activities in experimental models. Hesperidin is hydrolyzed into hesperetin in the gastrointestinal tract and is conjugated during absorption; the bioactive properties of hesperidin are particularly mediated by the hesperetin-7-O-β-d-glucuronide conjugate in animal models.
These chemical compositions confer antioxidant properties to sweet orange peel, which can protect the body from oxidative damage caused by free radicals. One of the most important pharmacological aspects of flavonoids is considered to be the antioxidant and free radical scavenging activities.
In an azoxymethane-induced mouse model of colon cancer, hesperidin was found to alter the anti-apoptotic scenario by modulating the Bax/Bcl-2 ratio together with enhanced release of cytochrome-c and activation of caspase-3/9. Experimental studies revealed that hesperidin initiates apoptosis by inhibiting constitutively activated Aurora-A-mediated PI3K/Akt/GSK-3β pathway, and mTOR pathway, coupled with stimulation of autophagy.
Hesperidin has also been shown to inhibit learning and memory impairments resulting from aluminum chloride-induced Alzheimer's disease, acting as an AChE inhibitor.
4. Scientific Evidence by Area of Use
4.1 Cardiovascular Health
The role of citrus flavanone hesperidin consumption on cardiovascular disease risk factors has been examined in many clinical trials, but conflicting results have been found.
A 2023 systematic review and meta-analysis published in a peer-reviewed journal examined the clinical trial evidence for hesperidin (the dominant flavanone in sweet orange alcohol extracts) on cardiovascular risk. The analysis included 12 trials with 589 participants and found evident effects of hesperidin on LDL cholesterol (WMD: −0.22 mmol/L; 95% CI: −0.33, −0.11 mmol/L), total cholesterol (WMD: −0.20 mmol/L; 95% CI: −0.31, −0.08 mmol/L), fasting blood glucose (WMD: −0.15 mg/dL; 95% CI: −0.29, −0.02 mg/dL), insulin sensitivity index, ICAM-1, VCAM-1, and C-reactive protein, whereas no effects were found for other cardiovascular risk factors. The findings demonstrate that hesperidin might be advantageous in improving numerous cardiovascular risk factors in humans.
Hesperidin and hesperetin counteract atherosclerosis, a key contributor to heart disease, by ameliorating lipid profiles, inhibiting plaque formation, and reducing inflammation.
Evidence strength: Moderate. The meta-analysis is based on 12 RCTs with 589 participants — a modest total sample size. Trials used hesperidin extracts, often sourced specifically from sweet orange, as the intervention, but the overall body of evidence is limited by small individual study sizes and heterogeneity in dosing and populations. Effects on blood pressure were not statistically significant in the meta-analysis.
4.2 Antioxidant Activity
Phytochemicals including phenolics and flavonoids in C. sinensis peel extracts exhibited good antioxidant properties. Among the extracts, 70% aqueous ethanol extract with the highest total phenolic content and high total flavonoid content showed the greatest antioxidant activity across multiple assay systems.
Different phenolic acids, organic acids, and flavonoids were also identified from the extracts; this study indicated that C. sinensis peels contain potential antioxidant compounds which could be exploited as value-added products in the food and pharmaceutical industries.
Evidence strength: Predominantly in vitro. Most antioxidant evidence comes from cell-free assays (FRAP, DPPH, CUPRAC) and cell-based experiments. Clinical human studies specifically measuring the in vivo antioxidant effect of sweet orange peel alcohol extracts as standalone interventions are limited.
4.3 Gastric and Hepatoprotective Effects
Animal studies have investigated the gastroprotective effects of Citrus sinensis peel aqueous and ethanolic extracts. Both Citrus sinensis peel aqueous extract (CSPE) and hesperidin significantly protect against all gastric damages caused by ethanol administration in rats. Results showed that ethanol-induced gastric damage improved oxidative stress markers (MDA and H₂O₂), increased pro-inflammatory cytokine TNF-α and COX-2 expression, and caused significant depletion of enzymatic and non-enzymatic antioxidants including GPx (72%), SOD (57.5%), CAT (41.6%), and -SH (50%).
Hesperidin exerted the best hepatoprotective, antioxidant, anti-inflammatory, and gastroprotective effects, followed by butanol and then aqueous citrus peel extracts.
Levels of biochemical parameters such as AST, ALT, NO, MDA, CRP, and IL-β6 were significantly reduced, but CAT level was increased in treated animals. Postmortem examination of liver and stomach tissues of treated animals revealed marked improvement compared with positive control animals.
Evidence strength: Preliminary; animal models only. No robust human clinical trial data specifically on sweet orange alcohol extract and gastroprotection are available as of current evidence review.
4.4 Antimicrobial and Anti-inflammatory Effects
Pharmacological activities including antioxidant, anticancer, antimicrobial, and anti-inflammatory properties of sweet orange peel have been investigated.
The plant is known for numerous activities such as antioxidant, antibacterial, antidiabetic, antifungal, antiosteoporosis, hypocholesterolemic, and antiobesity effects, due to the presence of phenolic acids, flavonoids, and essential oil components.
Evidence strength: Predominantly in vitro and animal studies. Human clinical evidence for these specific applications is lacking or very sparse.
4.5 Anticancer Activity (Preclinical)
A mixture containing only hydroxylated polymethoxyflavones (97.2%) induces apoptosis in breast cancer cells MCF-7 with a Minimal Effective Concentration (ECmin) of 4.62 µg/mL. Decreased development of tumors was studied in Apc (Min/+) mice when fed with 5% orange peel extract containing 30% polymethoxyflavones (tangeretin 19.0%, heptamethoxyflavone 15.24%, tetramethoxyflavone 13.6%, nobiletin 12.49%, hexamethoxyflavone 11.06%, and sinensetin 9.16%).
A recent study on identification of 4′-geranyloxyferulic acid (GOFA) among citrus peel extracts revealed that C. sinensis has the richest content of GOFA, which previously showed neuroprotective and dietary feeding colon cancer chemopreventive effects in rats.
Evidence strength: Preliminary; in vitro and animal models only. No human clinical trials have evaluated sweet orange alcohol extract specifically for cancer prevention or treatment.
4.6 Kidney Stone Prevention
The fruit and juice contain large amounts of citrate, which might help prevent kidney stones, as citrate tends to bind with calcium before it can form a stone. This mechanism has been studied in the context of orange juice consumption rather than concentrated alcohol extracts, and evidence is based on observational and small clinical data with juice, not extracts.
4.7 Neuroprotection (Preclinical)
Hesperidin corrected amyloid-beta-induced mitochondrial abnormalities by reducing MDA and H₂O₂ levels as well as restoring depleted GSH levels and total antioxidant capacity. Hesperidin also inhibited learning and memory impairments resulting from aluminum chloride-induced Alzheimer's disease, acting as an AChE inhibitor.
Evidence strength: Preliminary; animal models only. Human data on sweet orange extract or hesperidin and cognitive outcomes are not yet established.
5. Body Systems and Health Areas
- Cardiovascular system: Lipid modulation, blood pressure, endothelial function, anti-inflammatory markers (human RCT evidence for hesperidin).
- Gastrointestinal system: Gastroprotection, digestive stimulation, anti-ulcer activity (animal evidence; traditional use well-documented).
- Metabolic/endocrine system: Blood glucose regulation, insulin sensitivity (modest human RCT evidence for hesperidin).
- Hepatic system: Hepatoprotection against chemically induced injury (animal evidence).
- Immune system: Antioxidant activity, anti-inflammatory cytokine modulation (in vitro and animal data).
- Nervous system: AChE inhibition, neuroprotection against oxidative stress (animal models only).
- Integumentary system (skin): Antioxidant, mild exfoliant, brightening, antimicrobial activity in cosmetic applications.
6. Dosage Forms and Reported Dosages
Dosages reported in the peer-reviewed literature refer primarily to hesperidin (the principal active constituent) rather than to whole sweet orange alcohol extract, as most clinical trials isolate or standardize on hesperidin. Reported figures below are taken directly from published sources:
- In a clinical bioavailability study, 500 mg of sweet orange extract (providing hesperidin) was administered in two forms: (1) a mixture of hesperidin isomers -S and -R, and (2) more than 90% of the isomer -S, both micronized to 90% of particles less than 10 µm in size.
- In animal hepatoprotective and gastroprotective experiments, groups were treated for 2 weeks before disease induction with either citrus aqueous or butanol extracts or hesperidin at doses of 125–250 mg/kg.
- In a 90-day sub-chronic and acute oral toxicity study on Sprague Dawley rats, hesperidin isolated from the dehydrated peel of C. sinensis showed a low observed adverse effect level (LOAEL) at 1 g/kg, and a median lethal dose (LD50) of 4.83 g/kg.
- In clinical RCTs included in the 2023 meta-analysis, hesperidin doses ranged across different studies but were drawn from preparations including sweet orange extracts; individual trial dosage specifics were not uniformly reported in the aggregated publication.
- In single-strength orange juice, hesperidin content ranges from 555 to 761 mg/L, whereas in concentrated juice it ranges from 470 to 614 mg/L.
As a cosmetic ingredient, citrus aurantium dulcis (orange) fruit water is used at up to 19% in paste masks and mud packs, according to 2013 industry survey data. For cosmetic alcohol extracts, standardized use concentration data in specific product categories varies by formulator and is not uniformly published in peer-reviewed sources.
7. Safety Considerations and Drug Interactions
7.1 General Safety Profile
The sweet orange (Citrus × sinensis (L.) Osbeck) is considered fairly innocuous due to the lack of CYP3A-inhibiting furanocoumarins in the fruit. Limonene and other terpene-rich citrus flavor ingredients, such as oil, essential oil, whole fruit extract, and peel extract, are generally recognized as safe (GRAS) by the FDA.
The safety profile of hesperidin in animal studies is considered good, as the concentrations needed to cause adverse effects are much higher than those used to obtain health benefits (10–200 mg/kg). Other citrus flavonoids, including nobiletin, tangeretin, and naringin, have similarly shown a good safety profile.
R-(+)-limonene has shown a no-observed adverse effect level (NOAEL) in rodents ranging from less than 75 to 500 mg/kg, and LD50 values range from 4.40 to 6.60 g/kg.
7.2 Drug Interactions: OATPs and Bioavailability Reduction
Unlike grapefruit juice, sweet orange juice does not substantially inhibit intestinal CYP3A4 due to the absence of furanocoumarins. However, it can inhibit organic anion-transporting polypeptides (OATPs), reducing drug absorption. Clinical studies with fexofenadine, certain β-blockers, and fluoroquinolones have demonstrated that orange juice can reduce systemic exposure by up to 83%. This is particularly relevant for concentrated alcohol extracts where the flavanone load may be higher than in ordinary juice.
Varieties of sweet orange do not produce the same CYP3A4-inhibiting interaction as grapefruit, Seville orange, limes, and pomelos. This is a pharmacokinetically important distinction: sweet orange alcohol extracts are not expected to elevate plasma levels of CYP3A4-substrate drugs in the way that grapefruit juice does.
7.3 CYP Enzyme Modulation by Citrus Peel Extracts
Research on closely related citrus species has raised questions about CYP enzyme modulation that may be relevant to sweet orange alcohol preparations. Citrus peel ethanol extracts were shown to induce P-gp excretion, and citrus peel induced metabolism and decreased the intracellular concentration of a CYP3A4 substrate, while not affecting it by the same mechanism as immature orange extract. These findings suggest that bioavailability of CYP3A4 substrates may decrease via the upregulation of P-gp and CYP3A4 in intestinal epithelial cells when citrus peel is administered.
Fructus aurantii (bitter orange) contains many compounds, such as flavonoids, which have been reported to impact the expressions of CYP450; however, the effect of these preparations on CYP450 still requires further investigation for full characterization. These preclinical findings warrant awareness when sweet orange alcohol extract is co-administered with drugs that are substrates of CYP3A4 or P-glycoprotein.
7.4 Photosensitivity
Sweet orange peel oil can contain trace furocoumarins depending on preparation method. The Cosmetic Ingredient Review (CIR) Expert Panel noted that for leave-on cosmetic products, citrus peel preparations should be formulated to be non-sensitizing and non-irritating. Leave-on products should not contain more than 0.0015% (15 ppm) 5-methoxypsoralen (5-MOP), per the CIR safety assessment. For ingested preparations of sweet orange alcohol, photosensitivity is not considered a clinically documented concern based on available evidence.
7.5 Allergenicity
Potential constituents that are established contact allergens in humans are noted in SCCS assessments of citrus ingredients, categorized according to number of patients reacting positively. Limonene and linalool — both present in sweet orange alcohol extracts — are among the most common fragrance allergens identified in the European regulatory system and must be declared on cosmetic labels above threshold concentrations.
7.6 Pregnancy and Pediatric Populations
No robust human clinical data from peer-reviewed sources specifically addressing the safety of concentrated sweet orange alcohol extracts in pregnancy or pediatric populations were identified in the available literature. Ordinary consumption of orange juice and fruit is widely accepted as safe. Concentrated ethanolic extracts carry the additional consideration of ethanol content, which varies by preparation but may be relevant in sensitive populations.
References
Go back